Using magnetomotive ultrasound to improve diagnosis in rectal cancer
Magnetomotoric Ultrasound for Diagnostic Purposes in Rectal Cancer
This study tests if a new type of ultrasound that uses magnets can help doctors better diagnose rectal cancer before surgery.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 28 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Sahlgrenska University Hospital Academic / other |
| Locations | 1 site (Gothenburg) |
| Trial ID | NCT04622176 on ClinicalTrials.gov |
What this trial studies
This study investigates the use of magnetomotive ultrasound (MMUS) as a diagnostic tool for rectal cancer. It combines standard ultrasound technology with an external magnetic field to enhance imaging capabilities. The effectiveness of MMUS will be compared against MRI results and pathology reports from surgical specimens. The goal is to improve preoperative diagnostics for patients undergoing surgery for rectal cancer.
Who should consider this trial
Good fit: Ideal candidates for this study are patients diagnosed with rectal cancer who are scheduled for abdominoperineal resection.
Not a fit: Patients who do not have rectal cancer or cannot provide informed consent will not benefit from this study.
Why it matters
Potential benefit: If successful, this approach could lead to more accurate preoperative diagnostics, potentially improving surgical outcomes for rectal cancer patients.
How similar studies have performed: While the use of ultrasound in cancer diagnostics is established, the specific application of magnetomotive ultrasound is novel and has not been extensively tested in prior studies.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Rectal cancer * Surgery with abdominoperineal resection Exclusion Criteria: * No informed consent * Not fulfilling inclusion criteria * No rectal cancer
Where this trial is running
Gothenburg
- Dept. of Surgery, Sahlgrenska University Hospital/Ostra — Gothenburg, Sweden (Recruiting)
Study contacts
- Principal investigator: Eva Angenete — Sahlgrenska Universitetssjukhuset
- Study coordinator: Eva Angenete, MD. PhD
- Email: eva.angenete@vgregion.se
- Phone: +46760-514441
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.